Nexien BioPharma (NXEN) Financial Statements
Nexien BioPharma Financial Overview
Nexien BioPharma's market cap is currently $7.08K. The company's EPS TTM is $-0.00; its P/E ratio is -0.03; Nexien BioPharma has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 24 | Jun 23 | Jun 22 | Jun 21 | Jun 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -156.00K | $ -283.00K | $ -340.74K | $ -750.10K | $ -2.64M |
| EBITDA | $ -337.00 | $ -233.24K | $ -8.00 | $ -233.00 | $ -35.42K |
| Net Income | $ -239.00K | $ -362.00K | $ -626.00K | $ -1.86M | $ -2.67M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 4.18K | $ 35.15K | $ 116.90K | $ 18.04K | $ 10.79K |
| Total Assets | $ 4.18K | $ 43.13K | $ 124.52K | $ 25.54K | $ 22.79K |
| Total Debt | $ 312.25K | $ 271.49K | $ 221.73K | $ 12.94K | $ 12.00K |
| Net Debt | $ 308.07K | $ 236.34K | $ 59.83K | $ -5.10K | $ 1.21K |
| Total Liabilities | $ 365.43K | $ 295.13K | $ 242.12K | $ 39.32K | $ 29.15K |
| Stockholders' Equity | $ -361.25K | $ -252.01K | $ -117.61K | $ -13.78K | $ -6.37K |
| Cash Flow | |||||
| Free Cash Flow | $ -64.36K | $ -81.75K | $ -75.14K | $ -90.75K | $ -147.57K |
| Operating Cash Flow | $ -64.36K | $ -81.75K | $ -75.14K | $ -90.75K | $ -147.57K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 33.40K | $ 0.00 | $ 174.00K | $ 98.00K | $ 12.00K |
Currency in USD
